Evaluation and management of hypertension

Indian Pediatrics

Volumn 44, Issue 2, 2007, Pages 103-121

  Bagga, Arvind ^a,b   Jain, Rupesh ^a   Vijayakumar, M ^a   Kanitkar, Madhuri ^a   Ali, Uma ^a  

^a Indian Academy of Pediatrics   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IRBESARTAN; ISRADIPINE; LABETALOL; LISINOPRIL; LOOP DIURETIC AGENT; LOSARTAN; METOLAZONE; METOPROLOL; MINOXIDIL; NIFEDIPINE; NITROPRUSSIDE SODIUM; PRAZOSIN; PROPRANOLOL; RAMIPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG;

ACUTE DISEASE; ACUTE GLOMERULONEPHRITIS; AGE DISTRIBUTION; ALBUMINURIA; ANAMNESIS; ANEMIA; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; BODY HEIGHT; BRAIN HEMORRHAGE; BRAIN INFARCTION; CHILDHOOD DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; COUGHING; CYANIDE POISONING; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DIET RESTRICTION; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DYSLIPIDEMIA; EMERGENCY CARE; ERYTHEMA; ESSENTIAL HYPERTENSION; EXERCISE; FACIAL NERVE PARALYSIS; FLUID RETENTION; FLUSHING; HEART LEFT VENTRICLE FAILURE; HEART PALPITATION; HUMAN; HYPERCALCIURIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; HYPERTENSION RETINOPATHY; HYPERTENSIVE CRISIS; HYPERTRICHOSIS; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LEG EDEMA; LIFESTYLE MODIFICATION; MEDICAL ASSESSMENT; METABOLIC ALKALOSIS; NEUTROPENIA; NEWBORN DISEASE; NUTRITIONAL ASSESSMENT; OSCILLOMETRY; PATIENT MONITORING; PERICARDIAL EFFUSION; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PROTEINURIA; REVIEW; SCREENING TEST; SEDATION; SIDE EFFECT; SLEEP DISORDER; SODIUM INTAKE; SPHYGMOMANOMETER; SPHYGMOMANOMETRY; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION; INDIA; INFANT; MALE; MASS SCREENING;

EID: 33847081266     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Munter P, He J, Cutler JA, Wildman RP, Whelton BK. Trends in blood pressure among children and adolescents. JAMA 2004; 291: 2107-2113.
2. Mohan B, Kumar N, Aslam N, Rangbulla A, Kumbkarni S, Sood NK, et al. Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana. Indian Heart J 2004; 56: 310-314.
3. Lane DA, Gill P. Ethnicity and tracking blood pressure in children. J Human Hypertension 2004; 18: 223-228.
4. National High Blood Pressure Education Program Working Group. The Fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (suppl): 555-576.
5. National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
6. Report of the Second Task Force on Blood Pressure Control in Children 1987. National Heart, Lung and Blood Institute, Bethesda, Maryland. Pediatrics 1987; 79: 1-25
7. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol 2005; 20: 1151-1155.
8. Pickering TG. Principles and techniques of blood pressure measurement. Cardiol Clin 2002; 20: 207-223.
9. Working Group on Blood Pressure Monitoring of the European Society of Hypertension. International protocol for validation of blood pressure measuring devices in adults. Blood Pressure Monit 2002; 7: 3-17.
10. Butani L, Morgenstern BZ. Are pitfalls of oscillometric blood pressure measurements preventable in children? Pediatr Nephrol 2003; 18: 313-318.
11. Srivastava RN, Bagga A. Hypertension. In: Srivastava RN, Bagga A. Pediatric Nephrology, 4th ed. New Delhi: Jaypee Brothers, 2005, p. 292-315.
12. Hari P, Bagga A, Srivastava RN. Hypertension in children. Indian Pediatr 2000; 37: 268-274.
13. Croix B, Feig DI. Childhood hypertension is not a silent disease. Pediatr Nephrol 2006; 21: 527-532.
14. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356: 411-417.
15. Linakis J. The assessment and management of hypertensive emergencies and urgencies in children. Pediatr Emergency Care 2005, 21: 391-396.
16. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol 2005; 20: 961-966.
17. Council on Sports Medicine and Fitness and Council on School Health. Active healthy living: prevention of childhood obesity through increased physical activity. Pediatrics 2006; 117: 1834-1842.
18. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Athletic participation by children and adolescents who have systemic hypertension. Pediatrics 1997; 99: 637-638.
19. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension. A scientific statement from the American Heart Association. Hypertension 2006; 47: 296-308.
20. Bhave S, Bavdekar A, Otiv M, IAP National Task Force for childhood prevention of adult diseases: Childhood obesity. Indian Pediatr 2004; 41: 559-575.
21. Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A., et al. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 2005; 64: 35-40.
22. Kaplan NM, Opie L.H. Controversies in hypertension. Lancet 2006; 367: 168-176.
23. Hogg RJ, Furth S, Lemley KV, Portman R., Schwartz GJ, Coresh J, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification and stratification. Pediatrics 2003; 111: 1416-1421.
24. Fenves AZ, Ram CV. Drug treatment of hypertensive urgencies and emergencies. Semin Nephrol 2005; 25: 272-280.
25. Calvetta A, Martino S, von Vigier RO, Schmidtko J, Fossali E, Bianchetti MG. What goes up must immediately come down! Which indication for short-acting nifedipine in children with arterial hypertension? Pediatr Nephrol 2003; 18: 1-2.
26. Yiu V, Orrbine E, Rosychuk RJ, MacLaine P, Goodyer P, Girardin C, et al. The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatr Nephrol 2004; 19: 644-650.